Glutamine antagonist-mediated immune suppression decreases pathology but delays virus clearance in mice during nonfatal alphavirus encephalomyelitis.
about
N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive Disorders.Germline IgM is sufficient, but not required, for antibody-mediated alphavirus clearance from the central nervous system.IL-10 modulation of virus clearance and disease in mice with alphaviral encephalomyelitis.Death and gastrointestinal bleeding complicate encephalomyelitis in mice with delayed appearance of CNS IgM after intranasal alphavirus infection.
P2860
Glutamine antagonist-mediated immune suppression decreases pathology but delays virus clearance in mice during nonfatal alphavirus encephalomyelitis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Glutamine antagonist-mediated ...... alphavirus encephalomyelitis.
@en
type
label
Glutamine antagonist-mediated ...... alphavirus encephalomyelitis.
@en
prefLabel
Glutamine antagonist-mediated ...... alphavirus encephalomyelitis.
@en
P2093
P2860
P1433
P1476
Glutamine antagonist-mediated ...... alphavirus encephalomyelitis.
@en
P2093
Alicia M Braxton
Barbara S Slusher
Michelle C Potter
Rebecca Glowinski
P2860
P304
P356
10.1016/J.VIROL.2017.05.013
P407
P577
2017-05-19T00:00:00Z